Iacopo Sardi
- Genetics top 2%
- Glioma Diagnosis and Treatment 51
- Cancer Research top 5%
- Pharmacology top 2%
- Biophysics top 2%
- Oncology top 5%
-
- Neuroblastoma Research and Treatments 23
- Neurofibromatosis and Schwannoma Cases 9
-
- Brain Metastases and Treatment 9
- Sarcoma Diagnosis and Treatment 9
-
- Chromatin Remodeling and Cancer 9
-
- Meningioma and schwannoma management 9
-
- Genetic factors in colorectal cancer 8
- Co-authors
- Alessandro FranchiLorenzo GenitoriOreste GalloAlfredo VannacciLaura GiuntiEmanuela MasiniLucia MagnelliOrnella Fantappiè
- Cited by
- GeneticsCancer ResearchPharmacology
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (1 paper)Gastroenterology (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Iacopo Sardi
122 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 118
- Genetics 590
- Cancer Research 618
- Pharmacology 495
- Biophysics 139
- Oncology 614
Countries citing papers authored by Iacopo Sardi
This map shows the geographic impact of Iacopo Sardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iacopo Sardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iacopo Sardi more than expected).
Fields of papers citing papers by Iacopo Sardi
This network shows the impact of papers produced by Iacopo Sardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iacopo Sardi. The network helps show where Iacopo Sardi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Iacopo Sardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 10 | |
| 7 | 2022 | 9 | |
| 8 | 2017 | 12 | |
| 9 | Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing apoptosis. | 2015 | 36 |
| 10 | 2015 | 21 | |
| 11 | 2012 | 9 | |
| 12 | 2012 | 12 | |
| 13 | 2012 | 11 | |
| 14 | 2010 | 4 | |
| 15 | 2009 | 6 | |
| 16 | 2008 | 98 | |
| 17 | 2008 | 26 | |
| 18 | 2007 | 8 | |
| 19 | 2006 | 9 | |
| 20 | 2001 | 57 |
About Iacopo Sardi
Iacopo Sardi is a scholar working on Genetics, Neurology and Cancer Research, having authored 132 papers that have together received 3.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (51 papers), Neuroblastoma Research and Treatments (23 papers), Brain Metastases and Treatment (9 papers), Chromatin Remodeling and Cancer (9 papers), Sarcoma Diagnosis and Treatment (9 papers), Neurofibromatosis and Schwannoma Cases (9 papers), Meningioma and schwannoma management (9 papers) and Genetic factors in colorectal cancer (8 papers). The work is most often cited by research in Genetics (590 citations), Cancer Research (618 citations) and Pharmacology (495 citations). Iacopo Sardi has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Alessandro Franchi, Lorenzo Genitori, Oreste Gallo, Alfredo Vannacci, Laura Giunti, Emanuela Masini, Lucia Magnelli, Emanuela Masini, Ornella Fantappiè and Maurizio de Martino. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.